Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 110

    1.

    Effects of high-dose simvastatin therapy on glucose metabolism and ectopic lipid deposition in nonobese type 2 diabetic patients.

    Szendroedi J, Anderwald C, Krssak M, Bayerle-Eder M, Esterbauer H, Pfeiler G, Brehm A, Nowotny P, Hofer A, Waldhäusl W, Roden M.

    Diabetes Care. 2009 Feb;32(2):209-14. Epub 2008 Oct 28.PMID: 18957532 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.

    Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA.

    Diabetes Care. 2001 Apr;24(4):710-9.PMID: 11315836 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.

    Lewin AJ, Kipnes MS, Meneghini LF, Plotkin DJ, Perevozskaya IT, Shah S, Maccubbin DL, Mitchel YB, Tobert JA; Simvastatin/Thiazolidinedione Study Group.

    Clin Ther. 2004 Mar;26(3):379-89.PMID: 15110130 [PubMed - indexed for MEDLINE]Related articles

    4.

    Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.

    Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H.

    Diabetes. 1996 May;45(5):659-66. Erratum in: Diabetes 1996 Sep;45(9):1285. PMID: 8621019 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial.

    Jula A, Marniemi J, Huupponen R, Virtanen A, Rastas M, Rönnemaa T.

    JAMA. 2002 Feb 6;287(5):598-605.PMID: 11829698 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Jan;89(1):200-6.PMID: 14715850 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Lack of effect of simvastatin on insulin sensitivity in Type 2 diabetic patients with hypercholesterolaemia: results from a double-blind, randomized, placebo-controlled crossover study.

    Hwu CM, Kwok CF, Chen HS, Shih KC, Lee SH, Hsiao LC, Lin SH, Ho LT.

    Diabet Med. 1999 Sep;16(9):749-54.PMID: 10510951 [PubMed - indexed for MEDLINE]Related articles

    8.

    The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

    Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.

    Diabetes Care. 1998 May;21(5):701-5.PMID: 9589227 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of insulin on cholesterol synthesis in type II diabetes patients.

    Scoppola A, Testa G, Frontoni S, Maddaloni E, Gambardella S, Menzinger G, Lala A.

    Diabetes Care. 1995 Oct;18(10):1362-9.PMID: 8721938 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.

    Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA.

    Diabetes. 2003 Jun;52(6):1364-70.PMID: 12765945 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of simvastatin and metformin on inflammation and insulin resistance in individuals with mild metabolic syndrome.

    Bulcão C, Ribeiro-Filho FF, Sañudo A, Roberta Ferreira SG.

    Am J Cardiovasc Drugs. 2007;7(3):219-24.PMID: 17610348 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.

    Dobs AS, Schrott H, Davidson MH, Bays H, Stein EA, Kush D, Wu M, Mitchel Y, Illingworth RD.

    Metabolism. 2000 Sep;49(9):1234-8.PMID: 11016911 [PubMed - indexed for MEDLINE]Related articles

    13.

    Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.

    Bajaj M, Suraamornkul S, Hardies LJ, Pratipanawatr T, DeFronzo RA.

    Int J Obes Relat Metab Disord. 2004 Jun;28(6):783-9.PMID: 15024400 [PubMed - indexed for MEDLINE]Related articles

    14.

    The effect of gemfibrozil on lipid profile and glucose metabolism in hypertriglyceridaemic well-controlled non-insulin-dependent diabetic patients. For the Gemfibrozil Study Group.

    Avogaro A, Piliego T, Catapano A, Miola M, Tiengo A.

    Acta Diabetol. 1999 Jun;36(1-2):27-33.PMID: 10436249 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cholesterol levels after 3 days of high-dose simvastatin in patients at moderate to high risk for coronary events.

    Michelena HI, Osorio LA, Citkowitz E.

    Int J Cardiol. 2005 May 11;101(1):111-4.PMID: 15860392 [PubMed - indexed for MEDLINE]Related articles

    16.

    Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

    Maggs DG, Buchanan TA, Burant CF, Cline G, Gumbiner B, Hsueh WA, Inzucchi S, Kelley D, Nolan J, Olefsky JM, Polonsky KS, Silver D, Valiquett TR, Shulman GI.

    Ann Intern Med. 1998 Feb 1;128(3):176-85.PMID: 9454525 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.

    Torlone E, Britta M, Rambotti AM, Perriello G, Santeusanio F, Brunetti P, Bolli GB.

    Diabetes Care. 1993 Oct;16(10):1347-55.PMID: 8269792 [PubMed - indexed for MEDLINE]Related articles

    18.

    Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients.

    Koh KK, Quon MJ, Han SH, Lee Y, Ahn JY, Kim SJ, Koh Y, Shin EK.

    Diabetes Care. 2008 Apr;31(4):776-82. Epub 2008 Jan 9.PMID: 18184901 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.

    Cusi K, Consoli A, DeFronzo RA.

    J Clin Endocrinol Metab. 1996 Nov;81(11):4059-67.PMID: 8923861 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of simvastatin versus gemfibrozil on lipids and glucose control in patients with non-insulin-dependent diabetes mellitus. NIDDM Study Group.

    Sweany AE, Shapiro DR, Tate AC, Goldberg RB, Stein EA.

    Clin Ther. 1995 Mar-Apr;17(2):186-203.PMID: 7614520 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data